Browsing Tag

$Diffusion Pharma

Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing…

Jason Junior Oct 25, 2022

CHARLOTTESVILLE, Va., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that may enhance the body’s ability to deliver…

Health

Diffusion Pharmaceuticals Doses First Patients in ILD-DLCO Trial

Jason Junior Dec 17, 2021

CHARLOTTESVILLE, Va., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver…

Health

Diffusion Pharmaceuticals Issues Letter to Shareholders

Jason Junior Sep 9, 2021

CHARLOTTESVILLE, Va., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to…

Health

Diffusion Pharmaceuticals Announces Clearance of IND Application for TSC by FDA’s Pulmonology,…

Jason Junior Aug 30, 2021

Phase 2 DLCO Trial in Interstitial Lung Disease Expected to Begin in Q4 Under New IND Fourth FDA Division to Clear TSC IND CHARLOTTESVILLE, Va., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) …